[The effect of amiridine and tacrine on reversible capture of neuromediators in experimental memory disorders].
Burov
Iu V
IuV
Baĭmanov
T D
TD
Robakidze
T N
TN
D000634:Aminoquinolines; D000818:Animals; D015306:Biogenic Monoamines / Q000378:metabolism*; D002800:Cholinesterase Inhibitors / Q000378:metabolism / Q000494:pharmacology* / Q000627:therapeutic use; D004195:Disease Models, Animal; D008297:Male; D008569:Memory Disorders / Q000188:drug therapy; D018377:Neurotransmitter Agents / Q000378:metabolism*; D018697:Nootropic Agents / Q000378:metabolism*; D051381:Rats; D012601:Scopolamine / Q000378:metabolism / Q000494:pharmacology / Q000627:therapeutic use; D013619:Tacrine / Q000378:metabolism / Q000494:pharmacology* / Q000627:therapeutic use
D000634:Aminoquinolines; D015306:Biogenic Monoamines; D002800:Cholinesterase Inhibitors; D018377:Neurotransmitter Agents; D018697:Nootropic Agents; D013619:Tacrine; C049860:amiridine; D012601:Scopolamine
Vliianie amiridina i takrina na obratnyĭ zakhvat neĭromediatorov v usloviiakh éksperimental'noĭ patologii pamiati.